Product Information
DECONEX IR 385-10 MG TABLET is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.6622 per EA under NDC 50991073690. Its NADAC has been published 330 times since Mar 22, 2017.
Strength
385; 10 mg/1; mg/1
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991073690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/8/2016
Pharmacological Classes
Price Statistics
The NADAC for DECONEX IR 385-10 MG TABLET has been published 330 times since Mar 22, 2017, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6622 per EA |
|---|---|
| All-time high | $0.7080 (Mar 14, 2018) |
| All-time low | $0.5988 (Mar 22, 2017) |
| 52-week high | $0.6622 |
| 52-week low | $0.6622 |
| Median price | $0.6160 |
| Average price | $0.6287 |
| Largest weekly change | +15.7% (Feb 21, 2018) |
| Weeks tracked | 330 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Guaifenesin and Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DECONEX IR 385-10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DECONEX IR 385-10 MG TABLET, manufactured by Poly Pharmaceuticals, Inc., is $0.6622 per EA (NDC 50991073690), effective Feb 11, 2026.
How has the price of DECONEX IR 385-10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DECONEX IR 385-10 MG TABLET has risen 10.6%. It has been tracked across 330 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for DECONEX IR 385-10 MG TABLET?
Since Mar 22, 2017, the NADAC for DECONEX IR 385-10 MG TABLET has ranged from a low of $0.5988 (Mar 22, 2017) to a high of $0.7080 (Mar 14, 2018), with a median of $0.6160 per EA.
Are there cheaper alternatives to DECONEX IR 385-10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DECONEX IR 385-10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures DECONEX IR 385-10 MG TABLET?
DECONEX IR 385-10 MG TABLET (NDC 50991073690) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification